DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
- Niravath, Polly A. (PI)
- Chang, Jenny C. (Key Personnel)
- Darcourt, Jorge (Key Personnel)
- Heyne, Kirk (Key Personnel)
- Singh, Monisha (Key Personnel)
Project: Clinical Trial